au.\*:("DEL PRATO, Stefano")
Results 1 to 25 of 100
Selection :
The place of sulfonylureas in the therapy for type 2 diabetes mellitusDEL PRATO, Stefano; PULIZZI, Nicolo.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S20-S27, SUP1Conference Paper
Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005DEL PRATO, Stefano.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, 29 p., SUP1Conference Proceedings
Proceedings of the 4th World Congress on Controversies to Consensus in Diabetes Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. 2013, Vol 36, issn 0149-5992, 233 p., SUP2Conference Proceedings
Proceedings of the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, 287 p.Serial Issue
Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper
The importance of first-phase insulin secretion : implications for the therapy of type 2 diabetes mellitusDEL PRATO, Stefano; TIENGO, Antonio.Diabetes/metabolism research and reviews (Print). 2001, Vol 17, Num 3, pp 164-174, issn 1520-7552Article
Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?DEL PRATO, Stefano; DARDANO, Angela; BIANCHI, Cristina et al.Diabetes care. 2013, Vol 36, issn 0149-5992, S198-S204, SUP2Conference Paper
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 DiabetesBURANT, Charles F.Diabetes care. 2013, Vol 36, issn 0149-5992, S175-S179, SUP2Conference Paper
Heart in Diabetes: A Microvascular DiseaseLAAKSO, Markku.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S145-S149Article
Comparative Efficiency and Safety of Pharmacological Approaches to the Management of ObesityHAINER, Vojtech.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S349-S354Article
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 DiabetesRAZ, Itamar.Diabetes care. 2013, Vol 36, issn 0149-5992, S139-S144, SUP2Conference Paper
The Case for: Hypoglycemia Is of Cardiovascular ImportanceLALIC, Nebojsa M.Diabetes care. 2013, Vol 36, issn 0149-5992, S264-S266, SUP2Conference Paper
Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 DiabetesLEBOVITZ, Harold E.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S225-S230Article
Incretin Effects on β-Cell Function, Replication, and Mass: The human perspectiveGARBER, Alan J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S258-S263Article
Myocardial, Perivascular, and Epicardial FatIOZZO, Patricia.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S371-S379Article
Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you needBITZUR, Rafael.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S380-S382Article
Changing the Treatment Paradigm for Type 2 DiabetesDEL PRATO, Stefano; PENNO, Giuseppe; MICCOLI, Roberto et al.Diabetes care. 2009, Vol 32, Num 3, pp 5217-5222, issn 0149-5992, 6 p., SUPConference Paper
Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetesVORA, Jiten.Diabetes care. 2013, Vol 36, issn 0149-5992, S226-S232, SUP2Conference Paper
Insulin Therapy and CancerHOME, Philip.Diabetes care. 2013, Vol 36, issn 0149-5992, S240-S244, SUP2Conference Paper
Role of Bile Acid Sequestrants in the Treatment of Type 2 DiabetesHANDELSMAN, Yehuda.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S244-S250Article
Limitations and Future Treatment Options in Type 2 Diabetes With Renal ImpairmentRITZ, Eberhard.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S330-S334Article
β-cell function and anti-diabetic pharmacotherapyDEL PRATO, Stefano; BIANCHI, Cristina; MARCHETTI, Piero et al.Diabetes/metabolism research and reviews (Print). 2007, Vol 23, Num 7, pp 518-527, issn 1520-7552, 10 p.Article
Overcoming the hurdles to achieving glycemic controlSHAW, Kenneth M.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, 6S-S9, SUP1Conference Paper
Cardiovascular Importance of Hyperglycemia and HypoglycemiaTKAC, Ivan.Diabetes care. 2013, Vol 36, issn 0149-5992, S267-S271, SUP2Conference Paper
DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factorsDICKER, Dror.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S276-S278Article